ARTICLE | Company News
GlycoMimetics, Pfizer deal
August 3, 2015 7:00 AM UTC
GlycoMimetics received a $20 million milestone payment from Pfizer under an October 2011 deal granting the pharma exclusive, worldwide rights to develop and commercialize rivipansel ( GMI-1070). The m...